Merz, J; Rofa, K; Karnbrock, L; Von Garlen, S; Dimanski, D; Koenig, S; Bulatova, K; Schaefer, I; Peikert, A; Albrecht, P; Hoppe, N; Bode, C; Zirlik, A; Stachon, P.
Knockout of purinergic receptor Y13 (P2Y13) results in an improved outcome of metabolic syndrome in mice.
EUR HEART J. 2020; 41: 3824-3824.
[Poster]
Web of Science